Inicio › Artritis psoriásica › Carolina del Norte
Ensayos clínicos de Artritis psoriásica en Carolina del Norte
11 estudios sobre Artritis psoriásica buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
Texto oficial del estudio (inglés)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06807424A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
- Onsite Clinical Solutions, Salisbury
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07321873A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
ReclutandoFase 1
Edades de 18 en adelante · Mujeres · Actualizado el 18 sept 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accellacare of Hickory, Hickory
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Joint and Muscle Research Institute ( Site 5108), Charlotte
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Charlotte
- Clinical Site, Leland
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- DJL Clinical Research | Charlotte, NC, Charlotte
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06671496A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
ReclutandoFase 3
Edades de 5 a 17 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06100744A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
ReclutandoFase 4
Edades de 18 en adelante · Mujeres · Actualizado el 28 ago 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- y 1 más
ReclutandoEstudio observacional
Hasta los 21 · Todos los sexos · Actualizado el 27 ago 2026 · NCT02418442Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Evidera, a PPD Business Unit /ID# 238688, Morrisville
ReclutandoEstudio observacional
Todas las edades · Mujeres · Actualizado el 17 jul 2025 · NCT04846959De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.